RE:UPDATE 1-Ackman sells part of Mondelez stakeGuy I know is on my case to get interested in VRX. My cash is tied up in some nice runs at the moment.
Are there any bull here capable of telling me why it's better to buy now versus waiting 45 days or so? When is all the US government stuff going to be dealt with because regardless how attactive this company looks at $43 CDN, that's something that investors like me hates!
Yes, one could argue "it's all priced in" but is it? How do you price in "politics"? The word alone stinks up the stock!
The cycle on this doesn't seem right but man, there's blood everywhere! Does Valeant make anything for that? LOL
So Biovail buys Valeant for $3.3B, grows the company to some big fat valuation of $100B and short sellers pop the bubble because Valeant got "very creative"? And we expect all corporations to be squeeky clean? Like the markets too right?
Got it! LOL
I'm very interested but firmly on the sidelines here, behind a thick plexiglass. Just perked in to say to my associate: Interested but not now.... Better plays out there for better short term returns.
Let's recheck in a few weeks to see who much the wolves have chewed this one and see what's left.
Any guess what Ackman will do with the cash? LOL!!!!
Defaulter wrote:
BOSTON, March 16 (Reuters) - Billionaire investor William Ackman adjusted his battered hedge fund portfolio on Wednesday when he sold 20 million shares of snack maker Mondelez International, one day after another key holding, Valeant Pharmaceuticals, lost half of its value. In a three paragraph letter sent to investors after the close of trading on Wednesday and seen by Reuters, Ackman said his firm, Pershing Square, has no plans to sell other investments right now and has "substantial uninvested cash." The letter came one day after Pershing Square lost about $800 million when Valeant was pummeled after raising the possibility that it may default on its debt and posting a worse-than-expected financial outlook. Ackman's Pershing Square Holdings has now lost 26.4 percent since January, marking one of the worst performances in the hedge fund industry this year.